SCLP.L Scancell Holdings plc
P/E
--
Forward P/E
-9.027778
Price/Sales
22.099163
Beta
0.687
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Scancell Sets October 20 Vote on 10-for-1 Share Consolidation
Scancell Holdings plc will hold a General Meeting on October 20, 2026, to seek shareholder approval for a share consolidation. Under the proposal, every 10...
Scancell Secures $25M BlackRock Funding for Phase 3 Melanoma Trial
Scancell Holdings plc secured a debt financing facility of up to $25 million from funds managed by BlackRock. The capital will fund a registrational Phase 3...
Scancell Prepares Phase III Melanoma Trial, Citing 77% Survival Success
Scancell Holdings plc presented an update on its lead cancer vaccine, iSCIB1+, at the H.C. Wainwright 28th Annual Global Investment Conference. The company...
🟢 Scancell Holdings is trading 5% up today as catalyst remains unclear
Scancell Holdings is trading 5.05% up at £10.40, although no clear company-specific announcement dated September 9, 2026 was identified. - The latest reported...